Stocktoria

EUPRAXIA PHARMACEUTICALS INC. EPRX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-09 · LEI

EUPRAXIA PHARMACEUTICALS INC. statistics & valuation

Market cap$595.8M
P / B7.3×
Return on equity-47.0%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-237.50% -1273.40% -76.30% -47.00% 2022202320242025
Shares outstanding
21.6M 27.3M 35.6M 51.9M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-96.70% -139.30% -73.00% -44.80% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$0.96 -$1.17 -$0.76 -$1.03 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-44.8%-73.0%-139.3%-96.7%
Return on equity-47.0%-76.3%-1273.4%-237.5%
Current ratio15.1211.101.026.08

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.